Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 8
2005 11
2006 13
2007 8
2008 2
2009 3
2010 16
2011 39
2012 31
2013 29
2014 33
2015 22
2016 29
2017 40
2018 34
2019 22
2020 31
2021 26
2022 18
2023 25
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

376 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean toshihide asano (1 results)?
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Khanna D, Lin CJF, Furst DE, Goldin J, Kim G, Kuwana M, Allanore Y, Matucci-Cerinic M, Distler O, Shima Y, van Laar JM, Spotswood H, Wagner B, Siegel J, Jahreis A, Denton CP; focuSSced investigators. Khanna D, et al. Lancet Respir Med. 2020 Oct;8(10):963-974. doi: 10.1016/S2213-2600(20)30318-0. Epub 2020 Aug 28. Lancet Respir Med. 2020. PMID: 32866440 Clinical Trial.
Secukinumab in plaque psoriasis--results of two phase 3 trials.
Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C; ERASURE Study Group; FIXTURE Study Group. Langley RG, et al. N Engl J Med. 2014 Jul 24;371(4):326-38. doi: 10.1056/NEJMoa1314258. Epub 2014 Jul 9. N Engl J Med. 2014. PMID: 25007392 Free article. Clinical Trial.
Systemic sclerosis.
Asano Y. Asano Y. J Dermatol. 2018 Feb;45(2):128-138. doi: 10.1111/1346-8138.14153. Epub 2017 Dec 10. J Dermatol. 2018. PMID: 29226387 Review.
The wound/burn guidelines - 6: Guidelines for the management of burns.
Yoshino Y, Ohtsuka M, Kawaguchi M, Sakai K, Hashimoto A, Hayashi M, Madokoro N, Asano Y, Abe M, Ishii T, Isei T, Ito T, Inoue Y, Imafuku S, Irisawa R, Ohtsuka M, Ogawa F, Kadono T, Kawakami T, Kukino R, Kono T, Kodera M, Takahara M, Tanioka M, Nakanishi T, Nakamura Y, Hasegawa M, Fujimoto M, Fujiwara H, Maekawa T, Matsuo K, Yamasaki O, Le Pavoux A, Tachibana T, Ihn H; Wound/Burn Guidelines Committee. Yoshino Y, et al. Among authors: asano y. J Dermatol. 2016 Sep;43(9):989-1010. doi: 10.1111/1346-8138.13288. Epub 2016 Mar 12. J Dermatol. 2016. PMID: 26971391
Vasculopathy in scleroderma.
Asano Y, Sato S. Asano Y, et al. Semin Immunopathol. 2015 Sep;37(5):489-500. doi: 10.1007/s00281-015-0505-5. Epub 2015 Jul 8. Semin Immunopathol. 2015. PMID: 26152638 Review.
Targeting B cells for treatment of systemic sclerosis.
Terui H, Segawa Y, Asano Y. Terui H, et al. Among authors: asano y. Curr Opin Rheumatol. 2023 Nov 1;35(6):317-323. doi: 10.1097/BOR.0000000000000961. Epub 2023 Aug 3. Curr Opin Rheumatol. 2023. PMID: 37540776 Review.
Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis.
Kuzumi A, Yoshizaki A, Matsuda KM, Kotani H, Norimatsu Y, Fukayama M, Ebata S, Fukasawa T, Yoshizaki-Ogawa A, Asano Y, Morikawa K, Kazoe Y, Mawatari K, Kitamori T, Sato S. Kuzumi A, et al. Among authors: asano y. Nat Commun. 2021 Oct 12;12(1):5947. doi: 10.1038/s41467-021-26099-w. Nat Commun. 2021. PMID: 34642338 Free PMC article.
376 results